Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Imbert

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Idrugs : the Investigational Drugs Journal|July 8, 2005
alpha2-Adrenoreceptor antagonistsP Mayer, T Imbert
Bioorganic & Medicinal Chemistry Letters|November 26, 1999
A new efficient synthesis of efaroxanP Mayer, P Brunel, T Imbert
British Journal of Cancer|November 15, 2000
Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerasesA Kruczynski, C Etiévant, D Perrin, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfationR P Garay, J P Labaune, D Mesangeau, et al.
Anti-Cancer Drug Design|June 17, 1998
Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin seriesC Etievant, P Schambel, Y Guminski, et al.
Journal of Medicinal Chemistry|November 7, 1998
Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611L Daley, Y Guminski, P Demerseman, et al.
Biochemical Pharmacology|March 16, 2000
F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of actionD Perrin, B van Hille, J M Barret, et al.
Leukemia Research|January 26, 2010
A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatmentJ-P Annereau, V Brel, C Dumontet, et al.
Journal of Medicinal Chemistry|October 6, 2000
New substituted 1-(2,3-dihydrobenzo[1, 4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with alpha(2)-adrenoceptor antagonist activityP Mayer, P Brunel, C Chaplain, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Idrugs : the Investigational Drugs Journal|July 8, 2005
alpha2-Adrenoreceptor antagonistsP Mayer, T Imbert
Bioorganic & Medicinal Chemistry Letters|November 26, 1999
A new efficient synthesis of efaroxanP Mayer, P Brunel, T Imbert
British Journal of Cancer|November 15, 2000
Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerasesA Kruczynski, C Etiévant, D Perrin, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfationR P Garay, J P Labaune, D Mesangeau, et al.
Anti-Cancer Drug Design|June 17, 1998
Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin seriesC Etievant, P Schambel, Y Guminski, et al.
Journal of Medicinal Chemistry|November 7, 1998
Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611L Daley, Y Guminski, P Demerseman, et al.
Biochemical Pharmacology|March 16, 2000
F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of actionD Perrin, B van Hille, J M Barret, et al.
Leukemia Research|January 26, 2010
A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatmentJ-P Annereau, V Brel, C Dumontet, et al.
Journal of Medicinal Chemistry|October 6, 2000
New substituted 1-(2,3-dihydrobenzo[1, 4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with alpha(2)-adrenoceptor antagonist activityP Mayer, P Brunel, C Chaplain, et al.
Pageof 1